Literature DB >> 1482632

Controlled, multi-center trials are needed in pediatric nephrology.

S A Mendoza, B M Tune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1482632     DOI： 10.1007/bf00866484

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  2 in total

1.  Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents.

Authors:  S A Mendoza; V M Reznik; W R Griswold; A M Krensky; P D Yorgin; B M Tune
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.

Authors:  W R Griswold; B M Tune; V M Reznik; M Vazquez; D J Prime; P Brock; S A Mendoza
Journal:  Nephron       Date:  1987       Impact factor: 2.847
  2 in total
  1 in total

1.  Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide.

Authors:  G A Sa; J P Luis; E Mendonca; M Almeida; F C Rosa
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.